Vivos RDGL
OTC RDGL
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vivos (RDGL) Liabilities and Shareholders Equity (2010 - 2025)

Vivos' (RDGL) quarterly Liabilities and Shareholders Equity came in at $1.9 million in Q4 2025, down 16.38% year-over-year from $2.2 million in Q4 2024, and down 18.63% quarter-over-quarter from $2.3 million in Q3 2025.

Analysis

Vivos (RDGL) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends

Vivos has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $1.9 million for Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity fell 16.38% year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at $6.9 million (down 27.39% YoY), while the FY2025 annual figure was $1.9 million, down 16.38% from the prior year.
  • Liabilities and Shareholders Equity came in at $1.9 million for Q4 2025 at Vivos, down from $2.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.3 million in Q1 2025 to a low of $1.1 million in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.9 million, with a median of $1.8 million recorded in 2023.
  • Year-over-year, Liabilities and Shareholders Equity soared 3429.68% in 2021 and slumped 50.37% in 2022.
  • Over 5 years, Liabilities and Shareholders Equity stood at $1.6 million in 2021, then rose by 6.64% to $1.7 million in 2022, then slipped by 7.61% to $1.6 million in 2023, then soared by 38.71% to $2.2 million in 2024, then retreated by 16.38% to $1.9 million in 2025.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.9 million in Q4 2025, $2.3 million in Q3 2025, and $2.8 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 93.31 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 13.87 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 6.46 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 10.74 Bn
10 Vivos 23.21 Mn 23.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.87 Mn
Sep 30, 2025 2.30 Mn
Jun 30, 2025 2.78 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 2.23 Mn
Sep 30, 2024 1.24 Mn
Jun 30, 2024 1.77 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 1.61 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.79 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.74 Mn
Sep 30, 2022 2.05 Mn
Jun 30, 2022 1.11 Mn
Mar 31, 2022 1.31 Mn
Dec 31, 2021 1.63 Mn
Sep 30, 2021 2.04 Mn
Jun 30, 2021 2.23 Mn
Mar 31, 2021 2.52 Mn